Our Investment Philosophy
Research is at the heart of every investment process and decision made by our portfolio teams. Their investment decisions are fueled by intensive debate, painstaking quantitative and fundamental research and the knowledge gained through decades of experience. All of our investment professionals have equal access to the analytical thought that is the hallmark of our firm. We pride ourselves on providing high-quality investment solutions for our clients.
Capabilities
The Boston Company offers both traditional and alternative equity investment products, encompassing a wide array of U.S., non-U.S. and global strategies.
Click the links below to learn more about our products:
US
| Large Cap Dynamic Large Cap Value Equity Income Large Cap Core Large Cap Core 130/30 Large Cap Growth |
Mid Cap Mid Cap Growth Mid Cap Opportunistic |
| Small/Mid Cap Small Mid Cap Growth Small Mid Cap Opportunistic Small Mid Cap Value |
Small Cap Small Cap Growth Small Cap Opportunistic Small Cap Value |
Non-US and Global
| Global Global Core Global Small Cap |
Developed Markets ACWI ex-US Value International Core International Small Cap Non-US Value |
Emerging Markets Emerging Markets Core Emerging Markets Small Cap Emerging Markets Value |
Specialty
| Concentrated Portfolios Market Neutral Region/Country Specific Sector Specific US All Cap Custom Client Solutions |
Alternatives
The Boston Company has a long tenure in long/short equity investing, with over 18 years in Equity Market Neutral. Our long/short equity platform continues to evolve, building on this foundation coupled with the strength and experience of our investment teams. Our large equity asset base provides abundant access to company management teams and other resources, and our strategies are empowered with extensive research talent. With our Institutional quality risk management, operations and relationship management, we are well positioned for the changing hedge fund landscape.
The Boston Company currently offers several long/short equity strategies. For more information or to discuss our alternative equity capabilities, please contact John Havens, Director of Sales & Relationship Management, at 617 722 7031.
